[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer July 29, 2020
Beijing Boe Technology Development, Boe Technology Group present EPCAM-targeting agents July 27, 2020
Regeneron reports preclinical data on 89Zr-labeled REGN-5054 antibody for CD8+ T-cell monitoring July 24, 2020